ƾ֤2017¹ú¼Ê¸Î²¡¾Û»á(ILC 2017)ÉϵÄר¼Ò±¨¸æ£¬½«±ûÐ͸ÎÑײ¡¶¾Ñ¬È¾×÷ΪȫÉíÐÔ¼²²¡À´ÖÎÁÆ£¬¶ø²»µ«½öÊǸÎÔàµÄ²¢·¢Ö¢£¬¿ÉÄÜÓÐÖúÓÚïÔ̸ÎÔàѬȾʱ¸ÎÍâÌåÏֵı¬·¢¡£
À´×ÔÈðÊ¿ÈÕÄÚÍß´óѧҽԺÁÙ´²²¡Àíѧ¡¢Î¸³¦²¡Ñ§ºÍ¸ÎÔಡѧϵµÄFrancesco Negro²©Ê¿ÌåÏÖ£¬¡°ÓÐÖ¤¾ÝÅú×¢£¬HCV»¼Õß¾³£ËÀÓڷǸÎÔàÏà¹ØÒòËØ¡£ËäÈ»£¬Ö÷ÒªµÄËÀÒòÔµ¹ÊÔÓÉÕÕ¾ÉÀ´×Ô¸ÎÔ࣬µ«Ïã¸ÛµÄÒ»¸öÑо¿ÍŶÓÈ´ÊӲ쵽Ðí¶àÆäËûËÀÒò£¬°üÀ¨ÉöÔà¡¢´úл¼°ÐÄѪ¹Ü¼²²¡ÒòËØ£¬¶øÕâЩ²¢·¢Ö¢Ó벡¶¾Ñ¬È¾²¢²»Ïà¹Ø¡£¡±
Negro²©Ê¿Ôö²¹Ëµ£¬¡°Õâ²¢²»ÊÇеÄÐÅÏ¢£¬´ÓÀúÊ·À´¿´£¬ÎÒÃǺÜÔç¾ÍÖªµÀ±ûÐ͸ÎÑ×ÓëѪ¹ÜÑ×Óйء£ÕâЩ²¡¶¾¿ÉÄÜÒ²Éæ¼°Òý·¢²¡¶¾ÍâµÄÃâÒ߽鵼·´Ó¦¡£¡±
¾ÝNegro³Æ£¬Younossi¼°ÆäͬʵÄÊÓ²ìЧ¹ûÅú×¢£¬µ±»¼ÕßѬȾHCVʱ£¬¿ÉÄÜ·ºÆð¸ßµ¨ºìËØÑªÖ¢¡¢ÌÇÄò²¡ºÍÆäËû²¢·¢Ö¢¡£Arase¼°ÆäͬʵÄÊý¾ÝÏÔʾ£¬ÖÎÓúHCV¿ÉÒÔïÔÌÒ»°ëÒÔÉϵÄÌÇÄò²¡·¢²¡£¬¶øÀ´×ÔHsuµÄÊý¾ÝÏÔʾ£¬²¡¶¾ÖÎÁÆ¿ÉÄܻήµÍESLD¡¢¼±ÐÔ¹ÚÐIJ¡ºÍÖзçµÄΣº¦¡£
ÓÉHCVѬȾµ¼ÖµĸÎÍâÌåÏÖËùÔì³ÉµÄHCV¼²²¡¸ºµ£¿ÉÄÜÁîÈËÊܾª¡£ÏÖÔÚȱ·¦¼ä½Ó±¾Ç®µÄÆÊÎö£¬¼²²¡¸ºµ£¿ÉÄܺÜÊÇÑÏÖØ£¬ÓÈÆäÊÇÊÂÇéʱ·ºÆðÆ£ÀͺÍÊÂÇéʱ¼äµÄËðʧ¡£
±ðµÄ£¬ºÜÄÑ´ÓÆäËûºÏ²¢Ö¢ÖÐÊèÉ¢³öÕæÕýµÄ¸ÎÍâÌåÏÖ¡£NegroÖ¸³ö£¬ÓÐÊÓ²ìÐÔÖ¤¾ÝÅú×¢£¬·Ç¸Îϸ°û¿ÉÒýÆðÖÐÊàÉñ¾ÏµÍ³¹¦Ð§Õϰ£¬²¢Ö¸³öÓ°ÏìÄÚÉøÍ¸µÄÎïÖÊÉøÍ¸»á±¬·¢ÒȵºËضԿ¹¡£
¾ÝNegroÏÈÈÝ£¬Ïȱ»ÅжϳöÀ´µÄÊÇÉöÔಢ·¢Ö¢¡£¡°HCVÊÇÂýÐÔÉöÔ༲²¡µÄ·Ç¹Å°åΣÏÕÒòËØ£¬HCV»¼ÕßӦÿÄê¾ÙÐÐÂѰ×Äò¡¢ÑªÄòºÍEGFR¼ì²â£¬ÒÔ¼ì²â¿ÉÄܱ¬·¢µÄÉöÔ༲²¡¡±¡£¹ØÓÚÌÇÄò²¡ºÍÒȵºËضԿ¹£¬¼ÈÍùÊý¾Ý£¬ÓÈÆäÊÇ2000ÄêNHANESµÄÊý¾ÝÏÔʾ£¬Ïà½ÏÓÚÎÞHCVѬȾ»¼Õߣ¬HCVѬȾ»¼ÕßµÄÌÇÄò²¡·¢²¡ÂÊÎȲ½ÉÏÉý¡£ÕâÖÖÕ÷ÏóÔÚ40-49ËêºÍ50-59ËêÖ®¼äÓÐËù¼Ó¾ç¡£¹ØÓÚÐÄѪ¹Ü¼²²¡£¬NegroÒýÓÃÁËPetta¼°ÆäͬʵÄÊý¾Ý£¬Êý¾ÝÏÔʾHCV»¼Õߵľ±¶¯Âö°ß¿éÔö¶à£¬µ«ËûÒÔΪÎüÑÌÒ²ÊǸÃÊÂÎñ±¬·¢ÂʵÄÒòËØ£»²¡¶¾¶ÔÄÔѪ¹ÜÊÂÎñÒ²ÓÐÓ°Ï죬ËäȻҲÓÐÆäËûΣÏÕÒòËØ¡£
×ܵÄÀ´Ëµ£¬ÖÚ¶àÖ¤¾ÝÅú×¢£¬±ûÐ͸ÎÑ×ÔçÆÚÖÎÁÆ»ñÒæÏÔ×Å£¬µ«»¹ÐèÒª¸ü¶àµÄÊý¾ÝÀ´¾ÙÐÐÑéÖ¤¡£
ÐÅÔ´: Negro F. Joint Workshop EASL/Viral Hepatitis Group. Presented at: International Liver Congress; April 19-24, 2017; Amsterdam.


Ãö¹«Íø°²±¸ 35092602000113ºÅ